Clinical characteristics are compared between JAK2 V617F- and CALR-unmutated essential thrombocythemia, suggesting unique mutation profiles.
Patients with JAK2V617F- and CALR-unmutated ET tend to present at a younger age and exhibit a lower incidence of thrombosis compared to those with JAK2V617F-mutated ET. The application of WES enabled the detection of uncommon and potential driver mutations in JAK2V617F- and CALR-unmutated ET.
No takes yet. Share an insight, caveat, or question.
Thammayot et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: